Incuvate Sues Penumbra Over Alleged Patent Infringement of Thrombectomy Technology
Incuvate alleges that Penumbra’s THUNDERBOLT system infringes five of its patents covering blood-clot detection technology.
Incuvate alleges that Penumbra’s THUNDERBOLT system infringes five of its patents covering blood-clot detection technology.
Lilly is calling on regulators, customs agencies, law enforcement authorities, online platforms, and payment companies to shut down the illegal retatrutide black market.
Novo Nordisk alleges Lilly’s advertisements for Zepbound and Mounjaro mislead consumers by comparing the drugs with lower-dose versions of Wegovy and Ozempic.